Courriel : bd@sidmexinovia.com
Téléphone : +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Tacromus 0.5 mg Capsule
Manufacturer/Marketed By : Cadila Healthcare Ltd
$2.45 $1.61
Tacromus 0.5 mg capsules are an essential immunosuppressive medication primarily utilized to prevent organ rejection in transplant patients, such as those receiving a kidney, liver, or heart. By effectively dampening...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Tacrolimus 0.5 mg
Active Pharmaceutical Ingredient
Tacromus 0.5 mg Capsule
2,45 $US
1,61 $US
Tacromus 0.5 mg capsules are an essential immunosuppressive medication primarily utilized to prevent organ rejection in transplant patients, such as those receiving a kidney, liver, or heart. By effectively dampening the immune response, Tacromus aids in ensuring that the body accepts the new organ, thereby enhancing the success rate of the transplant procedure. This medication is often prescribed in conjunction with other therapies to optimize patient outcomes. However, it's important to be aware of potential side effects, including an increased risk of infections and changes in kidney function, necessitating regular monitoring by healthcare professionals. Patients should also inform their doctors of any existing medical conditions or medications they are taking to avoid adverse interactions. Using Tacromus responsibly under medical supervision can significantly improve the quality of life for transplant recipients. Always consult with your healthcare provider to understand the best treatment plan for your specific needs and to discuss any concerns regarding the use of this medication.
Active Pharmaceutical Ingredient
Uses
• Tacromus 0.5 mg capsule is primarily utilized to prevent organ rejection in patients who have undergone transplants. By suppressing the immune response, it helps maintain the viability of the transplanted organ. This is crucial for patients who rely on organ transplants for their survival and quality of life. The medication works effectively to create an environment where the body can accept the new organ.
• In addition to organ transplant prevention, Tacromus 0.5 mg capsule can be used in certain autoimmune conditions. By modulating the immune system, it aids in reducing inflammation and tissue damage associated with these disorders. This can lead to improved patient outcomes and enhanced daily functioning. Physicians may consider this option for patients struggling with chronic immune-mediated issues.
• Tacromus 0.5 mg capsule is often prescribed as part of a comprehensive treatment regimen for transplant patients. It may be combined with other immunosuppressive agents to optimize the prevention of rejection. This multi-faceted approach can significantly increase the chances of transplant success. Regular monitoring is essential to ensure the effectiveness of this treatment strategy.
• The use of Tacromus 0.5 mg capsule extends to pediatric transplant recipients as well. Children undergoing organ transplants face unique challenges, and this medication can be an integral part of their care. It helps ensure that their developing bodies can accept new organs while minimizing the risk of rejection. Tailoring the use of Tacromus to younger patients can lead to better long-term outcomes.
Benefits
Tacromus 0.5 mg Capsule prevents the rejection of transplanted organs, such as the kidney, liver, and heart. It works by suppressing the immune system, which reduces the risk of the body rejecting the transplanted organ. Tacromus 0.5 mg may also be effective in treating certain autoimmune disorders, such as lupus, sarcoidosis, and myasthenia gravis. Tacromus Capsule is less likely to cause infections compared to other immunosuppressive drugs. Tacromus 0.5 mg Capsule can be used in combination with other immunosuppressive medications, such as cyclosporine, to increase its effectiveness.
Side Effects
Like all medication, Tacromus 0.5 mg Capsule may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Pain around the transplanted kidney
• Pain or burning when you urinated
• Dark urine
• Yellowing of the skin or eyes
• Loss of muscle control
• Confusion
• Thinking problems
Common Side Effects
• Nausea
• Vomiting
• Stomach pain
• Headache
• Rash
• Fever
• Dizziness
• Sore Throat
• Cold
• Fast heart rate
• Low blood pressure
• Low blood glucose levels
• Diarrhoea
How To Use
Tacromus 0.5 mg Capsule on an empty stomach, at least 1 hour before or 2 hours after eating. The exact dosage and duration of treatment will be determined by a doctor and will depend on the individual's condition and response to the medication. It's very important to take Tacromus Capsule exactly as prescribed by your doctor and not to change the dose or stop taking Tacromus 0.5 Capsule without first consulting your doctor. It's also important to keep all appointments with your doctor and lab tests while taking this Tacromus to check your progress and monitor for side effects.
Safety Advice
• Alcohol: Drinking alcohol while taking Tacromus Capsule is not recommended. Alcohol may increase the risk of side effects or interfere with the effectiveness Tacromus 0.5 mg Capsule. Before drinking alcohol while taking any medicine, it is best to talk to your doctor or pharmacist.
• Kidney: Patients with kidney disease should use Tacromus Capsule with caution. It is important that patients with kidney disease monitor their kidney function closely while taking Tacromus 0.5 mg and report any unusual symptoms or changes in kidney function to their doctor or health care professional. The dose of Tacromus 0.5 mg Capsule may need to be adjusted in patients with kidney disease.
• Breastfeeding: Breast feeding is not recommended while you are taking Tacromus 0.5 Capsule. It is possible that Tacromus 0.5 mg may pass into breast milk and cause harm to the baby. It is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed if you are breastfeeding and taking Tacromus. Your doctor will be able to help you make the decision that is best for you and for the health of your baby.
• Liver: Patients with liver disease should use Tacromus 0.5 mg Capsule with caution. It is important that patients with liver disease monitor their liver function closely and report any unusual symptoms or changes to their doctor. The dose for Tacromus 0.5 Capsule may require adjustment in patients with liver disease.
• Pregnancy: The use of Tacromus 0.5 mg Capsule during pregnancy may not be safe as there is some evidence from animal studies that it may harm the developing foetus. It is important that you talk to your doctor about the potential risks and benefits of taking Tacromus Capsule while pregnant. Your doctor can help you make the best decision for you and your baby.
• Driving: Tacromus 0.5 mg Capsule may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Tacromus 0.5 mg.
Disclaimer
Sidmex Inovia s'efforce de fournir des informations exactes et fiables. Cependant, l'ensemble du contenu de ce site web, y compris les descriptions et compositions des produits, est fourni à titre informatif uniquement et ne saurait se substituer à un avis, un diagnostic ou un traitement médical professionnel.
Il est conseillé aux utilisateurs de consulter un professionnel de santé qualifié avant toute décision médicale. Les informations fournies ne doivent pas être utilisées pour l'autodiagnostic ou l'automédication.
Tous les produits présentés sont exclusivement destinés aux professionnels (B2B) et aux demandes de renseignements en gros. Sidmex Inovia ne promeut pas la consommation directe par les particuliers et vise à soutenir, et non à remplacer, la relation entre le professionnel de santé et le patient.
Les noms de produits, marques et logos appartiennent à leurs propriétaires respectifs et leur utilisation n'implique aucune affiliation ni aucun parrainage. Sidmex Inovia décline toute responsabilité quant aux conséquences découlant de l'utilisation des informations fournies sur ce site web.